

VCBeat Health Contact Us

China Healthcare Select

Vertical Industries 

Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory

Home J&J Upgraded — New Drug Approved in China, Q1 Revenue Beats

J&J Upgraded — New Drug Approved in China, Q1 Revenue Beats

May 23, 2026 00:47 CST Updated 01:28

Share:

Johnson & Johnson

Medical Device R&D and Manufacturer

VCBeat is a China healthcare market intelligence and ecosystem platform helping global healthtech companies, investors, and institutions understand China’s healthcare innovation, market entry, partnerships, regulation, financing, and BD landscape.

vcbeatglobal@vcbeat.net 

SERVICES

Partnership Development Market Entry Advisory Ecosystem Engagement Advisory

COMPANY

About VCBeat Why VCBeat Contact Us

CHANNELS

China Healthcare Select Insights MNC China Lens Events VB100 GMPC

MORE

PRIVACY VCBEAT CHINA

© 2025 VCBeat. All rights reserved.